department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Epsolay · pharmadog

pharmadog
drugs
Epsolay

drug

patient view →

benzoyl peroxide

Marketedupdated 2mo ago

by Galderma Laboratories LP

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

Epsolay

generic

benzoyl peroxide

indication

Rosacea

phase

marketed

Patent cliff

source: FDA Orange Book

first barrier falls

Feb 3, 2028

~1.6 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (25)

May 23, 2041formulationUS 12257348
Dec 27, 2040method-of-use (U-3356)US 11628155
Dec 27, 2040method-of-use (U-3356)US 12295935
Aug 18, 2040method-of-use (U-3356)US 11426378
Feb 19, 2040formulationUS 10933046
Feb 19, 2040method-of-use (U-3356)US 10945987
Feb 19, 2040method-of-use (U-3356)US 11541026
Feb 19, 2040method-of-use (U-3357)US 11865100
Feb 19, 2040method-of-use (U-3356)US 11877997
Feb 19, 2040method-of-use (U-3947)US 11986456
Nov 27, 2032formulationUS 9687465
Aug 5, 2029formulationUS 82884343.1y
Aug 5, 2029formulationUS 82884343.1y
Jun 3, 2029formulationUS 101371422.9y
Jun 3, 2029formulationUS 102200492.9y
Jun 3, 2029formulationUS 102200492.9y
Jun 3, 2029method-of-use (U-916)US 106249182.9y
Jun 3, 2029method-of-use (U-124)US 86636992.9y
Jun 3, 2029method-of-use (U-124)US 88950702.9y
Jun 3, 2029formulationUS 90788702.9y
Jun 3, 2029formulationUS 95047042.9y
Jun 3, 2029formulationUS 95612082.9y
Aug 8, 2028formulationUS 98681032.1y
Feb 3, 2028formulationUS 121569461.6y
Feb 3, 2028formulationUS 123503821.6y

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

🐶 often sniffed alongside

top 3

tagRecall39 co-mentions · 16 sources
tagDermatology27 co-mentions · 7 sources
company$CVSCVS HEALTH Corp1 co-mentions · 1 sources

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Trials studying benzoyl peroxide

—Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgarisactive not recruitingn=200
phase2Evaluating Benzoyl Peroxide for Preventing Recurrence of HSV-1 Outbreaks With Rescue Crossover Optionnot yet recruitingn=100
phase1A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris.completedn=382
phase3Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgariscompletedn=1,668
phase4Profiling the Skin Microbiome in Response to Altreno in Acne Patientscompletedn=25
N/AClinical Study Between Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel Formulationscompletedn=602
phase3Long-term Study of Efficacy/Safety of Adapalene/Benzoyl Peroxide Topical Gel in Acne Vulgaris Subjectscompletedn=452